Skip to main content
Top
Published in: Endocrine 1/2017

Open Access 01-01-2017 | Original Article

Frequency of Cushing’s syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center

Authors: Henrik Falhammar, Jan Calissendorff, Charlotte Höybye

Published in: Endocrine | Issue 1/2017

Login to get access

Abstract

Cushing’s syndrome due to ectopic adrenocorticotropic hormone production from adrenal medullary lesions has occasionally been described. We retrospectively reviewed all 164 cases of Cushing’s syndrome and 77 cases of pheochromocytomas during 10 years. Of all cases with Cushing’s syndrome, only two cases (1.2 %) were due to ectopic adrenocorticotropic hormone production from adrenal medullary lesions (one case of pheochromocytoma and one case of adrenal medullary hyperplasia). Of all pheochromocytomas only the above-mentioned case (1.3 %) also gave rise to an ectopic adrenocorticotropic hormone syndrome. The clinical presentation of adrenocorticotropic hormone-secreting pheochromocytoma and adrenal medullary hyperplasia can be anything from mild to dramatic. These are rare conditions important to bear in mind in the workup of a patient with Cushing’s syndrome or with pheochromocytoma. The identification of ectopic adrenocorticotropic hormone secretion from adrenal medullary lesions can be life-saving.
Literature
4.
go back to reference J.W. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K. Grebe, M.H. Murad, M. Naruse, K. Pacak, W.F. Young Jr., S. Endocrine, Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(6), 1915–1942 (2014). doi:10.1210/jc.2014-1498 CrossRefPubMed J.W. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K. Grebe, M.H. Murad, M. Naruse, K. Pacak, W.F. Young Jr., S. Endocrine, Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(6), 1915–1942 (2014). doi:10.​1210/​jc.​2014-1498 CrossRefPubMed
5.
go back to reference I. Ilias, D.J. Torpy, K. Pacak, N. Mullen, R.A. Wesley, L.K. Nieman, Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 90(8), 4955–4962 (2005). doi:10.1210/jc.2004-2527 CrossRefPubMed I. Ilias, D.J. Torpy, K. Pacak, N. Mullen, R.A. Wesley, L.K. Nieman, Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 90(8), 4955–4962 (2005). doi:10.​1210/​jc.​2004-2527 CrossRefPubMed
6.
go back to reference J. Kirkby-Bott, L. Brunaud, M. Mathonet, E. Hamoir, J.L. Kraimps, C. Tresallet, L. Amar, A. Rault, J.F. Henry, B. Carnaille, Ectopic hormone-secreting pheochromocytoma: a francophone observational study. World J. Surg. 36(6), 1382–1388 (2012). doi:10.1007/s00268-012-1488-1 CrossRefPubMed J. Kirkby-Bott, L. Brunaud, M. Mathonet, E. Hamoir, J.L. Kraimps, C. Tresallet, L. Amar, A. Rault, J.F. Henry, B. Carnaille, Ectopic hormone-secreting pheochromocytoma: a francophone observational study. World J. Surg. 36(6), 1382–1388 (2012). doi:10.​1007/​s00268-012-1488-1 CrossRefPubMed
8.
go back to reference K. Lois, A. Santhakumar, S. Vaikkakara, S. Mathew, A. Long, S.J. Johnson, R. Peaston, R.D. Neely, D.L. Richardson, J. Graham, T.W. Lennard, R. Bliss, M. Miller, S.G. Ball, S.H. Pearce, Woods, R. Quinton, Phaeochromocytoma and acth-dependent Cushing’s syndrome: tumor CRF-secretion can mimic pituitary Cushing’s disease. Clin. Endocrinol. (2015). doi:10.1111/cen.12960 K. Lois, A. Santhakumar, S. Vaikkakara, S. Mathew, A. Long, S.J. Johnson, R. Peaston, R.D. Neely, D.L. Richardson, J. Graham, T.W. Lennard, R. Bliss, M. Miller, S.G. Ball, S.H. Pearce, Woods, R. Quinton, Phaeochromocytoma and acth-dependent Cushing’s syndrome: tumor CRF-secretion can mimic pituitary Cushing’s disease. Clin. Endocrinol. (2015). doi:10.​1111/​cen.​12960
9.
go back to reference H. Falhammar, L. Frisen, A.L. Hirschberg, C. Norrby, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study. J. Clin. Endocrinol. Metab. 100(9), 3520–3528 (2015). doi:10.1210/JC.2015-2093 CrossRefPubMed H. Falhammar, L. Frisen, A.L. Hirschberg, C. Norrby, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study. J. Clin. Endocrinol. Metab. 100(9), 3520–3528 (2015). doi:10.​1210/​JC.​2015-2093 CrossRefPubMed
10.
go back to reference A.M. Isidori, G.A. Kaltsas, C. Pozza, V. Frajese, J. Newell-Price, R.H. Reznek, P.J. Jenkins, J.P. Monson, A.B. Grossman, G.M. Besser, The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J. Clin. Endocrinol. Metab. 91(2), 371–377 (2006). doi:10.1210/jc.2005-1542 CrossRefPubMed A.M. Isidori, G.A. Kaltsas, C. Pozza, V. Frajese, J. Newell-Price, R.H. Reznek, P.J. Jenkins, J.P. Monson, A.B. Grossman, G.M. Besser, The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J. Clin. Endocrinol. Metab. 91(2), 371–377 (2006). doi:10.​1210/​jc.​2005-1542 CrossRefPubMed
11.
go back to reference P. Gosset, M. Lecomte-Houcke, A. Duhamel, F. Labat-Moleur, M. Patey, J. Floquet, G. Viennet, N. Berger-Dutrieux, B. Caillou, B. Franc, [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study]. Annales de pathologie 19(6), 480–486 (1999)PubMed P. Gosset, M. Lecomte-Houcke, A. Duhamel, F. Labat-Moleur, M. Patey, J. Floquet, G. Viennet, N. Berger-Dutrieux, B. Caillou, B. Franc, [112 cases of sporadic and genetically determined pheochromocytoma: a comparative pathologic study]. Annales de pathologie 19(6), 480–486 (1999)PubMed
12.
15.
go back to reference L.K. Nieman, B.M. Biller, J.W. Findling, M.H. Murad, J. Newell-Price, M.O. Savage, A. Tabarin, S. Endocrine, Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100(8), 2807–2831 (2015). doi:10.1210/jc.2015-1818 CrossRefPubMedPubMedCentral L.K. Nieman, B.M. Biller, J.W. Findling, M.H. Murad, J. Newell-Price, M.O. Savage, A. Tabarin, S. Endocrine, Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100(8), 2807–2831 (2015). doi:10.​1210/​jc.​2015-1818 CrossRefPubMedPubMedCentral
16.
go back to reference I. Sakuma, S. Higuchi, M. Fujimoto, T. Takiguchi, A. Nakayama, A. Tamura, T. Kohno, E. Komai, A. Shiga, H. Nagano, N. Hashimoto, S. Suzuki, T. Mayama, H. Koide, K. Ono, H. Sasano, I. Tatsuno, K. Yokote, T. Tanaka, Cushing syndrome due to ACTH-secreting pheochromocytoma, aggravated by glucocorticoid-driven positive-feedback loop. J. Clin. Endocrinol. Metab. 101(3), 841–846 (2016). doi:10.1210/jc.2015-2855 CrossRefPubMed I. Sakuma, S. Higuchi, M. Fujimoto, T. Takiguchi, A. Nakayama, A. Tamura, T. Kohno, E. Komai, A. Shiga, H. Nagano, N. Hashimoto, S. Suzuki, T. Mayama, H. Koide, K. Ono, H. Sasano, I. Tatsuno, K. Yokote, T. Tanaka, Cushing syndrome due to ACTH-secreting pheochromocytoma, aggravated by glucocorticoid-driven positive-feedback loop. J. Clin. Endocrinol. Metab. 101(3), 841–846 (2016). doi:10.​1210/​jc.​2015-2855 CrossRefPubMed
Metadata
Title
Frequency of Cushing’s syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center
Authors
Henrik Falhammar
Jan Calissendorff
Charlotte Höybye
Publication date
01-01-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1127-y

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue

Pros and Cons in Endocrine Practice

Premixed insulin regimens in type 2 diabetes: pros

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.